Casanova J-L, Abel L. Mechanisms of viral inflammation and disease in humans. Science. 2021;374(6571):1080–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Casanova J-L, Abel L. From rare disorders of immunity to common determinants of infection: Following the mechanistic thread. Cell. 2022;185(17):3086–103.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Matuozzo D, Talouarn E, Marchal A, Zhang P, Manry J, Seeleuthner Y, et al. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19. Genome Med. 2023;15(1):22.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang Q. Human genetics of life-threatening influenza pneumonitis. Hum Genet. 2020;139(6–7):941–8.

Article  PubMed  PubMed Central  Google Scholar 

Bastard P, Gervais A, Le Voyer T, Rosain J, Philippot Q, Manry J, et al. Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths. Science Immunol. 2021;6(62):eabl4340.

Article  Google Scholar 

Namkoong H, Edahiro R, Takano T, Nishihara H, Shirai Y, Sonehara K, et al. DOCK2 is involved in the host genetics and biology of severe COVID-19. Nature. 2022;609(7928):754–60.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Niemi ME, Daly MJ, Ganna A. The human genetic epidemiology of COVID-19. Nat Rev Genet. 2022;23(9):533–46.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Asano T, Boisson B, Onodi F, Matuozzo D, Moncada-Velez M, Maglorius Renkilaraj MRL, et al. X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19. Science Immunol. 2021;6(62):eabl4348.

Article  Google Scholar 

Lévy R, Zhang P, Bastard P, Dorgham K, Melki I, Hadchouel A, et al. Monoclonal antibody-mediated neutralization of SARS-CoV-2 in an IRF9-deficient child. Proc Natl Acad Sci. 2021;118(45):e2114390118.

Article  PubMed  PubMed Central  Google Scholar 

Casanova J-L, Anderson MS. Unlocking life-threatening COVID-19 through two types of inborn errors of type I IFNs. J Clin Invest. 2023;133(3):e166283.

Uitto J, Saeidian AH, Youssefian L, Vahidnezhad H. Interpretation of genomic sequence variants in heritable skin diseases: A primer for clinicians. J Am Acad Dermatol. 2023;89(3):569–76.

Article  CAS  PubMed  Google Scholar 

Youssefian L, Vahidnezhad H, Saeidian AH, Mahmoudi H, Karamzadeh R, Kariminejad A, et al. A novel autosomal recessive GJB2-associated disorder: ichthyosis follicularis, bilateral severe sensorineural hearing loss, and punctate palmoplantar keratoderma. Hum Mutat. 2019;40(2):217–29.

Article  CAS  PubMed  Google Scholar 

Saeidian AH, Youssefian L, Vahidnezhad H, Uitto J. Research techniques made simple: whole-transcriptome sequencing by RNA-seq for diagnosis of monogenic disorders. Journal of Investigative Dermatology. 2020;140(6):1117–26. e1.

Youssefian L, Saeidian AH, Palizban F, Bagherieh A, Abdollahimajd F, Sotoudeh S, et al. Whole-transcriptome analysis by RNA sequencing for genetic diagnosis of mendelian skin disorders in the context of consanguinity. Clin Chem. 2021;67(6):876–88.

Article  PubMed  PubMed Central  Google Scholar 

Youssefian L, Saeidian AH, Saffarian Z, Ariamanesh M, Abdollahimajd F, Molkara S, et al. Whole-transcriptome Sequencing-Based Profiling of the Cutaneous Virome in Patients with Secondary Immunodeficiency. JID Innovations. 2024:100278.

Saeidian AH, Youssefian L, Naji M, Mahmoudi H, Barnada SM, Huang C, et al. Whole transcriptome–based skin virome profiling in typical epidermodysplasia verruciformis reveals α-, β-, and γ-HPV infections. JCI insight. 2023;8(5):e162558.

Saeidian AH, Youssefian L, Huang CY, Palizban F, Naji M, Saffarian Z, et al. Whole-transcriptome sequencing–based concomitant detection of viral and human genetic determinants of cutaneous lesions. JCI insight. 2022;7(8):e156021.

Vahidnezhad H, Youssefian L, Jazayeri A, Uitto J. Research techniques made simple: genome-wide homozygosity/autozygosity mapping is a powerful tool for identifying candidate genes in autosomal recessive genetic diseases. J Investig Dermatol. 2018;138(9):1893–900.

Article  CAS  PubMed  Google Scholar 

Vahidnezhad H, Youssefian L, Saeidian AH, Zeinali S, Touati A, Abiri M, et al. Genome-wide single nucleotide polymorphism-based autozygosity mapping facilitates identification of mutations in consanguineous families with epidermolysis bullosa. Exp Dermatol. 2019;28(10):1118–21.

Article  CAS  PubMed  Google Scholar 

Youssefian L, Saeidian AH, Tavasoli AR, Kalamati E, Naghipoor K, Hozhabrpour A, et al. Recalcitrant cutaneous warts in a family with inherited ICOS deficiency. J Investig Dermatol. 2022;142(9):2435–45.

Article  CAS  PubMed  Google Scholar 

Yeo G, Burge CB, editors. Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals. J Comput Biol. 2004;11(2-3):377–94.

Liu X, Li C, Mou C, Dong Y, Tu Y. dbNSFP v4: a comprehensive database of transcript-specific functional predictions and annotations for human nonsynonymous and splice-site SNVs. Genome Med. 2020;12(1):1–8.

Article  Google Scholar 

Dobbs K, Domínguez Conde C, Zhang S-Y, Parolini S, Audry M, Chou J, et al. Inherited DOCK2 deficiency in patients with early-onset invasive infections. N Engl J Med. 2015;372(25):2409–22.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alizadeh Z, Mazinani M, Shakerian L, Nabavi M, Fazlollahi MR. DOCK2 deficiency in a patient with hyper IgM phenotype. J Clin Immunol. 2018;38:10–2.

Article  CAS  PubMed  Google Scholar 

Alosaimi MF, Shendi H, Beano A, Stafstrom K, El Hawary R, Meshaal S, et al. T-cell mitochondrial dysfunction and lymphopenia in DOCK2-deficient patients. Journal of Allergy and Clinical Immunology. 2019;144(1):306–9. e2.

Sharifinejad N, Sadri H, Kalantari A, Delavari S, Noohi A, Aminpour Y, et al. First patient in the Iranian Registry with novel DOCK2 gene mutation, presenting with skeletal tuberculosis, and review of literature. Allergy Asthma Clin Immunol. 2021;17(1):1–8.

Article  Google Scholar 

Aytekin E, ÇAĞDAŞ AYVAZ D, Tan Ç, Cavdarli B, Bilgic I, Tezcan İ. Hematopoietic stem cell transplantation complicated with EBV associated hemophagocytic lymphohistiocytosis in a patient with DOCK2 deficiency. Turk J Pediatr. 2021;63(6):1072–77.

Li W, Sun Y, Yu L, Chen R, Gan R, Qiu L, et al. Multiple immune defects in two patients with Novel DOCK2 mutations result in recurrent multiple infection including live attenuated virus vaccine. J Clin Immunol. 2023;43(6):1193–207.

Arunachalam AK, Maddali M, Aboobacker FN, Korula A, George B, Mathews V, Edison ES. Primary immunodeficiencies in India: molecular diagnosis and the role of next-generation sequencing. J Clin Immunol. 2021;41:393–413.

Article  CAS  PubMed  Google Scholar 

Moens L, Gouwy M, Bosch B, Pastukhov O, Nieto-Patlàn A, Siler U, et al. Human DOCK2 deficiency: report of a novel mutation and evidence for neutrophil dysfunction. J Clin Immunol. 2019;39:298–308.

Article  CAS  PubMed  PubMed Central  Google Scholar 

El Hawary RE, Meshaal SS, Abd Elaziz DS, Alkady R, Lotfy S, Eldash A, et al. Genetic testing in Egyptian patients with inborn errors of immunity: a single-center experience. J Clin Immunol. 2022;42(5):1051–70.

Article  PubMed  Google Scholar 

Platt CD, Zaman F, Bainter W, Stafstrom K, Almutairi A, Reigle M, et al. Efficacy and economics of targeted panel versus whole-exome sequencing in 878 patients with suspected primary immunodeficiency. J Allergy Clin Immunol. 2021;147(2):723–6.

Article  CAS  PubMed  Google Scholar 

Al-Herz W, Chou J, Delmonte OM, Massaad MJ, Bainter W, Castagnoli R, et al. Comprehensive genetic results for primary immunodeficiency disorders in a highly consanguineous population. Front Immunol. 2019;9:3146.

Article  PubMed  PubMed Central  Google Scholar 

D’Astous-Gauthier K, Desjardins A, Marois L, Falcone EL, Chapdelaine H. DOCK2 deficiency diagnosed 18 years after hematopoietic stem cell transplantation. J Clin Immunol. 2021;41(6):1400–2.

Article  PubMed  Google Scholar 

Moundir A, Ouair H, Benhsaien I, Jeddane L, Rada N, Amenzoui N, et al. Genetic diagnosis of inborn errors of immunity in an emerging country: A retrospective study of 216 Moroccan patients. J Clin Immunol. 2023;43(2):485–94.

Article  CAS  PubMed  Google Scholar 

Bruusgaard-Mouritsen MA, Masmas T, Borgwardt L, Nazaryan-Petersen L, Heilmann C, Madsen HO, Vibeke MH. A novel DOCK2 variant in siblings with severe combined immunodeficiency. Scand J Immunol. 2023;97(3):e13243.

Article  CAS  PubMed  Google Scholar 

AlKhater SA, Alsaleh MA, Chevalier R, Casanova J-L, Béziat V, Jouanguy E, Zhang S-Y. A Saudi DOCK2-deficient patient with recurrent multiple infections including recalcitrant warts. Res Sq. 2024;Preprint.

Vignesh P, Rawat A, Kumrah R, Singh A, Gummadi A, Sharma M, Kaur A. Clinical, immunological, and molecular features of severe combined immune deficiency: a multi-institutional experience from India. Front Immunol. 2020;11:619146.

Article  CAS  PubMed  Google Scholar 

Marsh RA. Epstein-Barr virus and hemophagocytic lymphohistiocytosis. Front Immunol. 2018;8:1902.

Article